FTDZX (Franklin Str:Bio Dsc;Adv)
Net Asset Value: 99.29
1-Day Return:
-0.17 (-0.17%)
YTD Return as of 4/5/13:
18.47%
Classification: Health/Biotech Objective: Health/Biotech Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/05/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 18.47 | 30.29 | 20.47 | NA | NA |
| Classification | 14.95 | 22.65 | 15.66 | 12.19 | 11.14 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 10 | 13 | 13 | NA | NA |
Fund Stats
More| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | NA |
| Inception Date: | 9/1/09 |
| Manager Name, Tenure | McCulloch/Banks, 2009 / 2012 |
| Expense Ratio: | 0.97% |
|
Sales Charge:
Load Type:
|
Institutional Load 0.00% 0.00% |
Top 10 Holdings (As of 9/30/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Gilead Sciences Inc Ord | GILD | 9.01 |
| Biogen Idec Inc Ord | BIIB | 6.82 |
| Institutional Money Market Portfolio | NA | 6.71 |
| Celgene Corp Ord | CELG | 6.50 |
| Amgen Inc Ord | AMGN | 5.18 |
| Alexion Pharmaceuticals Inc Ord | ALXN | 4.88 |
| Onyx Pharmaceuticals Inc Ord | ONXX | 4.71 |
| Vertex Pharmaceuticals Inc Ord | VRTX | 3.80 |
| Ariad Pharmaceuticals Inc Ord | ARIA | 2.84 |
| Medivation Inc Ord | MDVN | 2.77 |
| % of Total Holdings | 53.22 | |
